TE
Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
$1.24 +0.81% (+$0.01)
1M +5.98%
Market Cap $85.3M
P/E Ratio -
Div. Yield -
ROE 102.69%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 16.94x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 102.69%
ROA 109.51%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 16.14x
Int. coverage -837.07x
Debt/Equity 0.00x
Stability
19 /100
Unstable EPS volatility 829.02%
Profitable years 0
Beta -0.25x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TELO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Erez Aminov
Employees
2
Headquarters
Miami
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report